Asia Pacific / Science & Health Jul 30, 2018
China orders medical institutions not to use recalled Huahai-made drug due to cancer risk
China's health regulator said Monday all domestic medical institutions must cooperate with authorities and not use the valsartan blood and heart drug made by Zhejiang Huahai Pharmaceutical that could pose cancer risks. The bulk manufacturer of the drug said earlier this month that it is ...
